Biotechne revenue
WebBio-Techne Corp revenue for the twelve months ending December 31, 2024 was $1.120B, a 8.77% increase year-over-year. Bio-Techne Corp annual revenue for 2024 was … WebBusiness unit leader with a record of delivering revenue growth and innovative research tools in the life sciences industry. My passion lies in developing and commercializing …
Biotechne revenue
Did you know?
WebJun 7, 2024 · In terms of fundamentals, Last quarter Bio-Techne reported $1.79 EPS on $243.6 million revenue. Earnings grew 29% last quarter, following 36% and 50% growth the prior two periods. Revenue grew 25% ... WebSep 30, 2024 · Bio-Techne's revenue growth from 2010 to 2024 is 310.93%. Bio-Techne has 2,250 employees, and the revenue per employee ratio is $491,377. Bio-Techne's …
WebJul 6, 2016 · /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) announced today that it has agreed to acquire Advanced Cell Diagnostics (ACD) for $250 million in cash... WebBio-Techne's main competitors include MilliporeSigma, Abcam, BioLegend, PeproTech, Merck Millipore and Cytiva. Compare Bio-Techne to its competitors by revenue, employee growth and other metrics at Craft.
WebTotal Enterprise Value to Total Revenue (ttm) 11.01. Markets data provided by S&P and by Xignite. Profitability Metrics. Gross Margin (ttm) 68.33%. Operating Margin (ttm) 25.71%. … WebCompany’s earnings for a period net of operating costs, taxes, and interest. 50.00M. -37.63%. Net profit margin. Measures how much net income or profit is generated as a …
WebApr 13, 2024 · Bio-Techne Corporation (NASDAQ: TECH) today announced it will present its portfolio of products and solutions to advance cancer research and enable cell and gene …
The company was founded in 1976 by Dr. Roger C. Lucas as Research and Diagnostic Systems, Inc. In 1985, it merged into Techne Corporation and became a public company. In March 2013, Charles (Chuck) Kummeth was named chief executive officer of the company. In July 2013, the company acquired Bionostics for $104 million. In February 2014, the company changed its name to Bio-Techne. greeley missouriWebApr 14, 2024 · The company had revenue of $271.58 million for the quarter, compared to analysts' expectations of $289.98 million. Bio-Techne had a return on equity of 15.87% … greeley metal supplyWebApr 14, 2024 · The firm had revenue of $271.58 million during the quarter, compared to the consensus estimate of $289.98 million. As a group, equities analysts forecast that Bio-Techne Co. will post 1.75 ... greeley middle easter groceryWebFeb 1, 2024 · Second quarter year-over-year organic growth for the segment was 7 percent, with acquisitions contributing 16 percent to revenue growth. Bio-Techne posted Q2 … greeley mexican foodWebAug 4, 2024 · Revenue. Net sales for the fourth quarter increased 11% to $288.2 million. Organic growth was 14% compared to the prior year with foreign currency exchange … flower girls hairstyles for weddingsWebBio-Techne's Mission is to build Epic Tools for Epic Science. We have a creative, caring team of colleagues throughout the world who bring unique perspectives and talents in support of that Mission and who embody our … greeley methadone clinicWebSep 30, 2024 · Over the past seven years under Kummeth, the 43-year-old biotech company has grown from $300 million to $750 million in annual revenue, largely the result of 15 corporate acquisitions. GROWING … greeley mobile homes for sale